FDA 定稿药物相关应用指南,制药行业表示欢迎
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
FDA 已定稿针对药物相关应用的指南,制药行业对此表示欢迎。STAT Health Tech 表示,将解读这份最终指南对数字疗法未来发展的意义。
![]()
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a look at FDA’s final guidance on drug-related apps and what it means for the future of digital therapeutics. Plus the latest in Katie’s reporting on marketing drugs over telehealth.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Health Tech Correspondent
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.
来源:STAT Pharma 医药频道 · statnews.com